Jason Ukman (@JasonUkman) header
Jason Ukman (@JasonUkman) profile picture

Managing editor @statnews, ex @washingtonpost editor. Contactable: [email protected]

Austin, TX
Joined August 2012
Photo by Jason Ukman (@JasonUkman)Photo by Jason Ukman (@JasonUkman)Photo by Jason Ukman (@JasonUkman)Photo by Jason Ukman (@JasonUkman)Photo by Jason Ukman (@JasonUkman)Photo by Jason Ukman (@JasonUkman)Photo by Jason Ukman (@JasonUkman)Photo by Jason Ukman (@JasonUkman)Photo by Jason Ukman (@JasonUkman)Photo by Jason Ukman (@JasonUkman)
3
11
20
3,608
Replying to @adamfeuerstein
@adamfeuerstein: So do you think that Dario at some point is going to find out that biology is going to kick his ass? Matt Gline, CEO of Roivant: I think Dario is going to find out that no one wants to go to an AI restaurant and eat an AI cheeseburger. That they want to go to an actual hospital and take an actual pill. #STATSummit
4
19
2,601
Matt Gline, Roivant CEO, on Anthropic's foray into biotech:
3
28
17
116
46,217
Science editor-in-chief Holden Thorpe gave the day’s first warning about the rise of science in China. He says he can see it in the papers researchers are trying to get published in the top scientific journal he edits. "Submissions from China continue to increase, not just in number but in quality, and submissions from the U.S. are going down,” Thorpe said. He later added: “The atmosphere there (China) is just so much more pro-science than it is here.” Here is a video.
20
57
22
139
41,723
I’m thrilled here to be here in Boston, one of my favorite cities on the planet, for today’s #STATSummit. Watch here for tweets and stories from STAT staff, or buy a virtual ticket… I’m very proud of this agenda. Here are some pictures from my jog the other day.
4
29
3,395
Fifty years ago, pioneering researcher Robert Gallo and his colleagues pursued basic research science and changed history. Sometimes you don't know where the work will lead. That, he writes in @statnews, is a lesson that should still matter. statnews.com/2026/10/09/robe…
1
4
5
610
Jason Ukman retweeted
U.S. health spending is on pace to cost almost $16,500 per person this year. And the biggest portion of an employer’s health spending — even for the largest corporations in the country — has remained the same since the 1980s: bit.ly/4edjsFi
1
3
1,691
Jason Ukman retweeted
This year, $NVS acquired Avidity Biosciences and with it, a powerful new drug for a small sliver of patients with Duchenne muscular dystrophy. Now, parents are clamoring for companies to rapidly apply that technology for their own kids.
1
2
12
2,006
I spoke with Caribou $CRBU CEO Rachel Haurwitz last night about the gut-wrenching decision to shut down after failing to raise money to move its off-the-shelf CAR-T for lymphoma into a Phase 3 study. “Biotech companies close all the time, usually because the idea didn’t work, or the drug didn’t work. So, you wind down. You learned something, and you move on,” Haurwitz said. “Our experience is incredibly disappointing. Our clinical signal is strong. The benefit to patients is compelling and commercial research shows the drug could be market-leading. But all of that isn’t enough in this fundraising environment to get over the hurdle to raise enough capital,” she added. statnews.com/2026/10/07/cari…
25
25
12
254
93,182
If you want to conduct scientific research involving issues related to race, your odds of getting NIH funding are getting tougher. statnews.com/2026/10/02/nih-…
2
2
282